☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Full approval
Astellas and Seagen's Padcev (enfortumab vedotin-ejfv) Receive the US FDA's Full Approval and Expands Indication for Patients with...
July 12, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.